Roman Skoracki named director of Ohio State’s Stefanie Spielman Comprehensive Breast Center

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

LifeCare Alliance and the Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Center and Richard J. Solove Research Institute announced a partnership aimed at enhancing access to breast cancer screening and diagnostics for underserved individuals across Ohio.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Vaping and smoking together increases lung cancer risk fourfold

People who both vape and smoke are four times more likely to develop lung cancer than people who just smoke, according to a new study published by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and College of Public Health.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Electronic prompt for surgeons may reduce breast cancer overtreatment

University of Pittsburgh and UPMC Hillman Cancer Center researchers have developed a novel prompt, or ‘nudge,’ embedded in the electronic health record that flags, for treating surgeons, older patients with early-stage breast cancer who may be at risk for unnecessary lymph node surgery.

July 19, 2024

Vol.50 No.29

In Brief

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.

July 12, 2024

Vol.50 No.28

In Brief

Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

Glen Barber was named director of the Center for Innate Immunity and Inflammation within the Pelotonia Institute for Immuno-Oncology at the Ohio State University Comprehensive Cancer Center—James Cancer Hospital and Solove Research Institute.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Chemotherapy disrupts gut microbiome in patients with breast cancer

Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.

July 12, 2024

Vol.50 No.28

Roman Skoracki named director of Ohio State’s Stefanie Spielman Comprehensive Breast Center

YOU MAY BE INTERESTED IN

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

Vaping and smoking together increases lung cancer risk fourfold

Electronic prompt for surgeons may reduce breast cancer overtreatment

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

Chemotherapy disrupts gut microbiome in patients with breast cancer

Renew today!

Subscriber content

Login